This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkle, R. A. Search for Related Content PubMed PubMed Citation Articles by Winkle, R. A. Pubmed/NCBI databases Medline Plus Health Information Arrhythmia

Circulation, Vol 57, 1116-1121, Copyright © 1978 by American Heart Association

ARTICLES

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy

RA Winkle

Twenty patients with frequent ventricular ectopic beats had a 5 1/2 hour ECG rhythm strip recorded. Individual patients showed a marked spontaneous variability from one half-hour to the next in the total number of ectopic beats (-99% to +1100%) and the occurrence of pairs or salvos. Although no patient received antiarrhythmic drugs, some patients showed a spontaneous change in arrhythmia which mimicked either drug suppression or drug-induced worsening of arrhythmias. If an antiarrhythmic drug had been given to these patients after the first half-hour, 65% would have been termed "drug responders," using the criteria of 50% reduction in ectopic beats and elimination of pairs or salvos during any half-hour period in the subsequent three hours. Spontaneous variability in ventricular ectopic beats causes serious problems when using ECG monitoring to evaluate antiarrhythmic drug response in individual patients. The arrhythmias averaged for the entire group remained stable during the recording period. Evaluating antiarrhythmic drugs by examining group response rather than individual patient response minimizes the effect of spontaneous variability.

This article has been cited by other articles:

				M. R. Rosen Blunderbuss to Mickey Mouse: The Evolution of Antiarrhythmic Targets Circulation, September 3, 2002; 106(10): 1180 - 1182. [Full Text] [PDF]

				P. J. Zimetbaum and M. E. Josephson The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice Ann Intern Med, May 18, 1999; 130(10): 848 - 856. [Abstract] [Full Text] [PDF]

				M. A. Wood, P. M. Simpson, B. S. Stambler, J. M. Herre, R. C. Bernstein, and K. A. Ellenbogen Long-term Temporal Patterns of Ventricular Tachyarrhythmias Circulation, May 1, 1995; 91(9): 2371 - 2377. [Abstract] [Full Text]

				E. J. Stanek, M. D. Schoen, and J. L. Bauman Issues in the Treatment of Ventricular Ectopy: Past, Present, and Future Controversy Journal of Pharmacy Practice, January 1, 1990; 3(5): 283 - 294. [PDF]

				P. L. McCollam and J. L. Bauman New Concepts in Antiarrhythmic Drug Monitoring Journal of Pharmacy Practice, January 1, 1989; 2(6): 393 - 402. [PDF]

				J. E. Madias, N. E. Madias, and H. P. Gavras Nonarrhythmogenicity of Diuretic-Induced Hypokalemia: [ill]ts Evidence in Patients With Uncomplicated Hypertension Arch Intern Med, November 1, 1984; 144(11): 2171 - 2176. [Abstract] [PDF]

				R. B. Whiting Ventricular Premature Contractions Which Should Be Treated? Arch Intern Med, November 1, 1980; 140(11): 1423 - 1426. [Abstract] [PDF]

				R. A. WINKLE Measuring Antiarrhythmic Drug Efficacy by Suppression of Asymptomatic Ventricular Arrhythmias Ann Intern Med, September 1, 1979; 91(3): 480 - 482. [Abstract] [PDF]

				R. H. HEISSENBUTTEL and J. T. BIGGER Jr. New Drugs: Bretylium Tosylate: A Newly Available Antiarrhythmic Drug for Ventricular Arrhythmias Ann Intern Med, August 1, 1979; 91(2): 229 - 238. [Abstract] [PDF]